$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-K Financial Statement

#000143774920010796 Filed on May 14, 2020

Income Statement

Concept	2019 Q1	2019	2018 Q4
Revenue	$551.6K	$2.268M	$1.720M
YoY Change	-34.44%	-43.94%	-43.79%
Cost Of Revenue	$604.1K	$2.461M	$1.010M
YoY Change	-48.79%	-40.89%	17.44%
Gross Profit	-$52.43K	-$193.7K	$700.0K
YoY Change	-84.49%	61.91%	-68.04%
Gross Profit Margin	-9.5%	-8.54%	40.7%
Selling, General & Admin	$1.377M	$5.037M	$1.750M
YoY Change	-5.8%	-5.57%	25.9%
% of Gross Profit			250.0%
Research & Development	$374.1K	$1.332M	$330.0K
YoY Change	-4.6%	-5.92%	0.0%
% of Gross Profit			47.14%
Depreciation & Amortization	$19.29K	$81.85K	-$450.0K
YoY Change	-8.22%	-3.27%	-209.76%
% of Gross Profit			-64.29%
Operating Expenses	$1.751M	$6.368M	$2.090M
YoY Change	-5.55%	-5.64%	21.51%
Operating Profit	$70.00	-$1.069M	-$1.390M
YoY Change	-100.0%	-1336325.0%	-395.74%
Interest Expense		$1.069M	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$1.804M	-$13.52M
YoY Change	-30059733.33%	96.82%
Pretax Income	-$1.800M	-$14.59M	-$1.380M
YoY Change	-17.81%	112.37%	-387.5%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$1.804M	-$14.59M	-$1.380M
YoY Change	-17.72%	112.39%	-387.5%
Net Earnings / Revenue	-326.95%	-643.37%	-80.23%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.029M	-$8.197M	-$788.6K
COMMON SHARES
Basic Shares Outstanding	13.99M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q1	2019	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$460.0K	$590.0K	$320.0K
YoY Change	-64.62%	84.38%	10.34%
Cash & Equivalents	$459.3K	$80.00K	$323.9K
Short-Term Investments		$510.0K
Other Short-Term Assets	$75.82K	$110.0K	$56.68K
YoY Change	40.3%	-91.41%	-48.41%
Inventory	$980.9K	$430.0K	$998.8K
Prepaid Expenses
Receivables	$740.4K	$130.0K	$1.574M
Other Receivables	$80.00K	$110.0K	$60.00K
Total Short-Term Assets	$3.557M	$1.370M	$4.229M
YoY Change	-34.8%	-67.61%	-39.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$152.7K	$660.0K	$148.6K
YoY Change	-20.88%	340.0%	-17.97%
Goodwill
YoY Change
Intangibles	$194.3K		$195.9K
YoY Change	10.76%		8.17%
Long-Term Investments
YoY Change
Other Assets	$310.0K	$240.0K	$330.0K
YoY Change	-16.22%	-27.27%	3200.0%
Total Long-Term Assets	$7.707M	$1.130M	$7.463M
YoY Change	-11.2%	-84.85%	-17.67%
TOTAL ASSETS
Total Short-Term Assets	$3.557M	$1.370M	$4.229M
Total Long-Term Assets	$7.707M	$1.130M	$7.463M
Total Assets	$12.28M	$2.500M	$11.69M
YoY Change	-24.73%	-78.61%	-27.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$472.6K	$920.0K	$481.3K
YoY Change	86.82%	91.67%	-3.6%
Accrued Expenses	$578.0K	$860.0K	$548.2K
YoY Change	10.16%	56.36%	-20.32%
Deferred Revenue	$333.2K		$196.6K
YoY Change			-61.29%
Short-Term Debt	$0.00	$2.260M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.655M	$4.390M	$1.226M
YoY Change	8.79%	256.91%	-47.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$420.0K	$390.0K
YoY Change
Total Long-Term Liabilities	$419.2K	$390.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.655M	$4.390M	$1.226M
Total Long-Term Liabilities	$419.2K	$390.0K	$0.00
Total Liabilities	$1.816M	$4.780M	$1.226M
YoY Change	19.38%	288.62%	-47.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$76.94M		-$75.13M
YoY Change	15.11%		12.01%
Common Stock	$1.399K		$1.398K
YoY Change	47.42%		81.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.189M	-$2.290M	$10.47M
YoY Change
Total Liabilities & Shareholders Equity	$12.28M	$2.500M	$11.69M
YoY Change	-24.73%	-78.61%	-27.28%

Cashflow Statement

Concept	2019 Q1	2019	2018 Q4
OPERATING ACTIVITIES
Net Income	-$1.804M	-$14.59M	-$1.380M
YoY Change	-17.72%	112.39%	-387.5%
Depreciation, Depletion And Amortization	$19.29K	$81.85K	-$450.0K
YoY Change	-8.22%	-3.27%	-209.76%
Cash From Operating Activities	$160.5K	-$1.850M	-$690.0K
YoY Change	-84.62%	14.68%	2.99%
INVESTING ACTIVITIES
Capital Expenditures	$23.39K	$28.75K	$30.00K
YoY Change	-28.81%	-44.77%	0.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$510.0K	-$30.00K
YoY Change		1600.0%	-50.0%
Cash From Investing Activities	-$25.13K	-$543.3K	$0.00
YoY Change	-23.52%	558.89%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		2.149M	-30.00K
YoY Change		24.12%
NET CHANGE
Cash From Operating Activities	160.5K	-1.850M	-690.0K
Cash From Investing Activities	-25.13K	-543.3K	0.000
Cash From Financing Activities		2.149M	-30.00K
Net Change In Cash	135.4K	-244.9K	-720.0K
YoY Change	-86.61%	-795.39%	2.86%
FREE CASH FLOW
Cash From Operating Activities	$160.5K	-$1.850M	-$690.0K
Capital Expenditures	$23.39K	$28.75K	$30.00K
Free Cash Flow	$137.1K	-$1.879M	-$720.0K
YoY Change	-86.44%	12.82%	2.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019	bkyi	Accrual Of Unpaid Preferred Stock Dividends AccrualOfUnpaidPreferredStockDividends
CY2018	bkyi	Accrual Of Unpaid Preferred Stock Dividends AccrualOfUnpaidPreferredStockDividends	198033
CY2019Q4	bkyi	Accrued Factoring Fees Current AccruedFactoringFeesCurrent	31458
CY2018Q4	bkyi	Accrued Factoring Fees Current AccruedFactoringFeesCurrent	19000
CY2019	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	301077
CY2018	bkyi	Adjustments To Additional Paid In Capital Preferred Stock Dividends Declared AdjustmentsToAdditionalPaidInCapitalPreferredStockDividendsDeclared	198033
CY2019	bkyi	Adjustments To Additional Paid In Capital Warrant Debt Discount Valuation AdjustmentsToAdditionalPaidInCapitalWarrantDebtDiscountValuation	595662
CY2019	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	843287
CY2018	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	1513237
CY2018	bkyi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	1035000
CY2019	bkyi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	2000000
CY2018	bkyi	Class Of Warrant Or Right Increase Due To Trigger Of Antidilution Provision Future ClassOfWarrantOrRightIncreaseDueToTriggerOfAntidilutionProvisionFuture	1492848
CY2019Q3	bkyi	Class Of Warrant Or Right Recorded As Debt Discount ClassOfWarrantOrRightRecordedAsDebtDiscount	595662
CY2018	bkyi	Conversion Of A1 Preferred Dividends Payable Amount Converted ConversionOfA1PreferredDividendsPayableAmountConverted	356015
CY2018	bkyi	Conversion Of B1 Preferred Dividends Payable Amount Converted ConversionOfB1PreferredDividendsPayableAmountConverted	472424
CY2019	bkyi	Debt Discount Issued With Convertible Note DebtDiscountIssuedWithConvertibleNote	550000
CY2018	bkyi	Debt Discount Issued With Convertible Note DebtDiscountIssuedWithConvertibleNote
CY2018	bkyi	Deemed Dividend Down Round Features DeemedDividendDownRoundFeatures
CY2018Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	164438
CY2019Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	233005
CY2018Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	221120
CY2019	bkyi	Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter	150000
CY2019	bkyi	Factoring Fees FactoringFees	203950
CY2018	bkyi	Factoring Fees FactoringFees	186845
CY2019	bkyi	Effective Income Tax Reconciliation Effect Of Net Operating Loss EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss	-0.22
CY2018	bkyi	Effective Income Tax Reconciliation Effect Of Net Operating Loss EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss	-0.21
CY2019	bkyi	Effective Income Tax Reconciliation Permanent Differences EffectiveIncomeTaxReconciliationPermanentDifferences	-0.02
CY2018	bkyi	Effective Income Tax Reconciliation Permanent Differences EffectiveIncomeTaxReconciliationPermanentDifferences
CY2019Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	122064
CY2019	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	50999
CY2018	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	202353
CY2019	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-29316
CY2018	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability
CY2019	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-41005
CY2018	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-1144961
CY2019	bkyi	Investment In Held To Maturity Debt Securities Term InvestmentInHeldToMaturityDebtSecuritiesTerm	P1Y
CY2019Q4	bkyi	Investment In Heldtomaturity Debt Securities Interest Rate InvestmentInHeldtomaturityDebtSecuritiesInterestRate	0.05
CY2019Q4	bkyi	Limit Of Bond LimitOfBond	20000000
CY2019	bkyi	Operational Costs Per Month OperationalCostsPerMonth	525000
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Banker Fees PaymentsOfStockIssuanceCostsBankerFees	193500
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Commitment Fees PaymentsOfStockIssuanceCostsCommitmentFees	50000
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Legal Fees PaymentsOfStockIssuanceCostsLegalFees	71330
CY2019	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
CY2018	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
CY2019	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	912707
CY2018	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	942692
CY2019	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees	595000
CY2018	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees
CY2019Q4	bkyi	Software License Rights SoftwareLicenseRights	73802
CY2018Q4	bkyi	Software License Rights SoftwareLicenseRights	7915610
CY2019Q4	bkyi	Software License Rights Current SoftwareLicenseRightsCurrent
CY2018Q4	bkyi	Software License Rights Current SoftwareLicenseRightsCurrent	1125000
CY2019Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	73802
CY2018Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	6790610
CY2019	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	35013
CY2018	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	37532
CY2019Q2	bkyi	Stock Issued During Period Shares Commitment Fees StockIssuedDuringPeriodSharesCommitmentFees	80000
CY2019Q2	bkyi	Stock Issued During Period Shares Commitment Fees StockIssuedDuringPeriodSharesCommitmentFees	200000
CY2019Q2	bkyi	Stock Issued During Period Shares Commitment Fees StockIssuedDuringPeriodSharesCommitmentFees	130000
CY2019Q3	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	266667
CY2019	bkyi	Stock Issued During Period Value Commitment Fees StockIssuedDuringPeriodValueCommitmentFees	595000
CY2018	bkyi	Stock Issued During Period Value Conversion Of A1 Preferred Stock StockIssuedDuringPeriodValueConversionOfA1PreferredStock
CY2018	bkyi	Stock Issued During Period Value Conversion Of B1 Preferred Stock StockIssuedDuringPeriodValueConversionOfB1PreferredStock
CY2019Q3	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	400000
CY2019	bkyi	Total Operating Expenses Before Impairment TotalOperatingExpensesBeforeImpairment	6368487
CY2018	bkyi	Total Operating Expenses Before Impairment TotalOperatingExpensesBeforeImpairment	6749307
CY2018	bkyi	Total Warrants Exercised TotalWarrantsExercised
CY2019	bkyi	Total Warrants Exercised TotalWarrantsExercised
CY2018	bkyi	Total Warrants Expired TotalWarrantsExpired	145841
CY2019	bkyi	Total Warrants Expired TotalWarrantsExpired	2392502
CY2018	bkyi	Total Warrants Forfeited TotalWarrantsForfeited
CY2019	bkyi	Total Warrants Forfeited TotalWarrantsForfeited
CY2019	bkyi	Warrant Debt Discount Valuation WarrantDebtDiscountValuation	595662
CY2018	bkyi	Warrant Debt Discount Valuation WarrantDebtDiscountValuation
CY2019Q4	bkyi	Warrants Exercisable WarrantsExercisable	3388474
CY2019Q4	bkyi	Warrants Exercisable Weighted Average Exercise Price WarrantsExercisableWeightedAverageExercisePrice	1.60
CY2019	bkyi	Warrants Exercisable Weighted Average Remaining Life WarrantsExercisableWeightedAverageRemainingLife
CY2017Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	3.81
CY2018Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	1.59
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001019034
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21212297
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q2	dei	Entity Public Float EntityPublicFloat	8200000
CY2019	dei	Entity Registrant Name EntityRegistrantName	BIO KEY INTERNATIONAL INC
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019	dei	Trading Symbol TradingSymbol	bkyi
CY2019Q4	bkyi	Warrants Outstanding Exercise Price WarrantsOutstandingExercisePrice	1.60
CY2017	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P2Y21D
CY2018	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P2Y18D
CY2019	bkyi	Warrants Outstanding Weighted Average Remaining Life WarrantsOutstandingWeightedAverageRemainingLife	P3Y343D
CY2019Q4	bkyi	Warrants Vested Or Expected To Vest WarrantsVestedOrExpectedToVest	3388474
CY2019Q4	bkyi	Warrants Vested Or Expected To Vest Weighted Average Exercise Price WarrantsVestedOrExpectedToVestWeightedAverageExercisePrice	1.60
CY2019	bkyi	Warrants Vested Or Expected To Vest Weighted Average Remaining Life WarrantsVestedOrExpectedToVestWeightedAverageRemainingLife
CY2018	bkyi	Weighted Average Exercise Price Warrant Increase Due To Trigger Of Antidilution Provision Feature WeightedAverageExercisePriceWarrantIncreaseDueToTriggerOfAntidilutionProvisionFeature	1.50
CY2018	bkyi	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised
CY2019	bkyi	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised
CY2018	bkyi	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	6
CY2019	bkyi	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	1.50
CY2018	bkyi	Weighted Average Exercise Price Warrants Forfeited WeightedAverageExercisePriceWarrantsForfeited
CY2019	bkyi	Weighted Average Exercise Price Warrants Forfeited WeightedAverageExercisePriceWarrantsForfeited
CY2018	bkyi	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	1.50
CY2019	bkyi	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	1.50
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2019Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	110941
CY2018Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	56682
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	919294
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	481269
CY2019Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1859785
CY2018Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3307817
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	139785
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1587817
CY2019Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2018Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2019Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	126000
CY2018Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1574032
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	126000
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1574032
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	686885
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	548232
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	105933
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	77133
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	193823
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	224135
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	772304
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	690452
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	87436402
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	85599140
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	942692
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	912707
CY2018	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	338845
CY2019	us-gaap	Advertising Expense AdvertisingExpense	317000
CY2018	us-gaap	Advertising Expense AdvertisingExpense	309000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	947720
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	980224
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	571332
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	424980
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	43256
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15596
CY2019Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	6957516
CY2019Q4	us-gaap	Assets Assets	2496698
CY2018Q4	us-gaap	Assets Assets	11692332
CY2019Q1	us-gaap	Assets Assets	12282674
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1366291
CY2018Q4	us-gaap	Assets Current AssetsCurrent	4229297
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1130407
CY2018Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	7463035
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	138679
CY2018	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	123171
CY2019Q4	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79013
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	323943
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	288721
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-244930
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	35222
CY2018Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0
CY2019Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.60
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1398969
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3780976
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3388474
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14411432
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13977868
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14411432
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13977868
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	1441
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1398
CY2019Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	155962
CY2018Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	154169
CY2019Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	231519
CY2018Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	319199
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	359212
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	196609
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	359212
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	196609
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	147000
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2461245
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4164190
CY2019	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	152000
CY2018	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	62000
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	50000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15002000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12735000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	84000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	91000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	894000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	644000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	474000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	474000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16511000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13981000
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5000
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	13000
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2019Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2018Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2019	us-gaap	Depreciation Depreciation	81852
CY2018	us-gaap	Depreciation Depreciation	84617
CY2019	us-gaap	Dividends Paidinkind DividendsPaidinkind
CY2018	us-gaap	Dividends Paidinkind DividendsPaidinkind	1428966
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.03
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.73
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P332D
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	731370
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	65000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	20000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	13000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	17000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	20000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	20000
CY2019	us-gaap	Gross Profit GrossProfit	-193717
CY2018	us-gaap	Gross Profit GrossProfit	-119648
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4000000
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821
CY2018Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	6957516
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	438025
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-17961
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-883671
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1341914
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	138653
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-139793
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	162603
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-311257
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-569710
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	51982
CY2019	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	54259
CY2018	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-53183
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-29819
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1843
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	154386
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	195906
CY2019	us-gaap	Interest Expense InterestExpense	1069134
CY2018	us-gaap	Interest Expense InterestExpense
CY2019	us-gaap	Interest Paid Net InterestPaidNet	72822
CY2018	us-gaap	Interest Paid Net InterestPaidNet
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	287761
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	496358
CY2019Q4	us-gaap	Inventory Net InventoryNet	429119
CY2018Q4	us-gaap	Inventory Net InventoryNet	998829
CY2019Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	141358
CY2018Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	502471
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	154
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	80
CY2019	us-gaap	Lease Cost LeaseCost	227781
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	618620
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	89226
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	160817
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	170853
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	197724
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	57594
CY2019Q4	us-gaap	Liabilities Liabilities	4781871
CY2018Q4	us-gaap	Liabilities Liabilities	1226110
CY2019Q1	us-gaap	Liabilities Liabilities	1816452
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2496698
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11692332
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12282674
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4391405
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1226110
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	390466
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2148727
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1731155
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-543310
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-82458
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1850347
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1613475
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-6868875
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-14588700
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14588700
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8495874
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13519720
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6868955
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2255454
CY2018Q4	us-gaap	Notes Payable Current NotesPayableCurrent
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-1068980
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	80
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	186246
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	116875
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	561026
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170560
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	135519
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	390466
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	454823
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	179105
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	116875
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	566479
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	602937
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	36458
CY2018	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y120D
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	182461
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	64359
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	110941
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	56682
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	143945
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	361273
CY2019	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	512821
CY2018	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1736
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	30398
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28753
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52060
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact
CY2018	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	198033
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	108397
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	150811
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	138216
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3217000
CY2018	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1875100
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	867813
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	839060
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95509
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	148608
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	564361
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	720000
CY2019	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	707000
CY2018	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1331667
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1415401
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89723016
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-75134316
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2267528
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4044542
CY2019Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	17248
CY2018Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	9436
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5036820
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5333906
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.84
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.43
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0233
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.027
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	992747
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.88
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	91531
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	32841
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	149866
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	44783
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	241334
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	351918
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.03
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.53
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1477493
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1588014
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1751724
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.91
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.72
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.51
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1594905
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.59
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.03
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.08
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.63
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.27
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.97
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.17
CY2019Q4	us-gaap	Share Price SharePrice	0.50
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y182D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y182D
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y229D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y109D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y62D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	891760
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	946435
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	41535
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2070000
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	37532
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35013
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-2285173
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10466222
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	13753295
CY2019	us-gaap	Sublease Income SubleaseIncome	566479
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic; font: inherit;">2.</div> <div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 18pt;">Our consolidated financial statements are prepared in accordance with GAAP as set forth in the Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC) and consider the various staff accounting bulletins and other applicable guidance issued by the U.S. Securities and Exchange Commission (SEC). These accounting principles require us to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, accounts receivable, inventory, intangible assets and long-lived assets, and income taxes. To the extent there are material differences between these estimates, judgments or assumptions and actual results, its consolidated financial statements will be affected. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does <div style="display: inline; font-style: italic; font: inherit;">not</div> require management’s judgment in its application. There are also areas in which management’s judgment in selecting among available alternatives would <div style="display: inline; font-style: italic; font: inherit;">not</div> produce a materially different result.</div></div></div>
CY2019	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
CY2018	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount	1428966
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14223685
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11607933

Files In Submission

Name	View Source	Status
0001437749-20-010796-index-headers.html	Edgar Link	pending
0001437749-20-010796-index.html	Edgar Link	pending
0001437749-20-010796.txt	Edgar Link	pending
0001437749-20-010796-xbrl.zip	Edgar Link	pending
bkyi-20191231.xml	Edgar Link	completed
bkyi-20191231.xsd	Edgar Link	pending
bkyi-20191231_cal.xml	Edgar Link	unprocessable
bkyi-20191231_def.xml	Edgar Link	unprocessable
bkyi-20191231_lab.xml	Edgar Link	unprocessable
bkyi-20191231_pre.xml	Edgar Link	unprocessable
bkyi20191231_10k.htm	Edgar Link	pending
bkyi20191231_10kimg001.jpg	Edgar Link	pending
ex_185717.htm	Edgar Link	pending
ex_185718.htm	Edgar Link	pending
ex_185719.htm	Edgar Link	pending
ex_185720.htm	Edgar Link	pending
ex_185721.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2019 Q1 Form 10-K Financial Statement

#000143774920010796 Filed on May 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2019 Q1 Form 10-K Financial Statement

#000143774920010796 Filed on May 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi